A detailed history of Trustcore Financial Services, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Trustcore Financial Services, LLC holds 100 shares of CRL stock, worth $20,148. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 172 41.86%
Holding current value
$20,148
Previous $34,000 38.24%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$197.11 - $250.07 $14,191 - $18,005
-72 Reduced 41.86%
100 $21,000
Q3 2022

Nov 03, 2022

BUY
$182.44 - $250.54 $13,135 - $18,038
72 Added 72.0%
172 $34,000
Q1 2022

May 09, 2022

BUY
$255.51 - $362.11 $25,551 - $36,211
100 New
100 $28,000
Q4 2021

Feb 09, 2022

SELL
$351.38 - $448.68 $35,138 - $44,868
-100 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$175.56 - $226.45 $17,556 - $22,645
100 New
100 $23,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.